Neurovascular Embolization Devices - Medical Devices Pipeline Assessment, 2020

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Neurovascular Embolization Devices Overview

3 Products under Development
3.1 Neurovascular Embolization Devices - Pipeline Products by Stage of Development
3.2 Neurovascular Embolization Devices - Pipeline Products by Segment
3.3 Neurovascular Embolization Devices - Pipeline Products by Territory
3.4 Neurovascular Embolization Devices - Pipeline Products by Regulatory Path
3.5 Neurovascular Embolization Devices - Pipeline Products by Estimated Approval Date
3.6 Neurovascular Embolization Devices - Ongoing Clinical Trials

4 Neurovascular Embolization Devices - Pipeline Products under Development by Companies
4.1 Neurovascular Embolization Devices Companies - Pipeline Products by Stage of Development
4.2 Neurovascular Embolization Devices - Pipeline Products by Stage of Development

5 Neurovascular Embolization Devices Companies and Product Overview
5.1 Ancure LLC Company Overview
5.1.1 Ancure LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aneuclose LLC Company Overview
5.2.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Artio Medical Company Overview
5.3.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
5.4 Avantec Vascular Corp Company Overview
5.4.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
5.5 Balt USA LLC Company Overview
5.5.1 Balt USA LLC Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioCure Inc Company Overview
5.6.1 BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cerenovus Company Overview
5.7.1 Cerenovus Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cerus Endovascular Ltd Company Overview
5.8.1 Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Collagen Matrix Inc Company Overview
5.9.1 Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 CranioVation Company Overview
5.10.1 CranioVation Pipeline Products & Ongoing Clinical Trials Overview
5.11 Dartmouth College Company Overview
5.11.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
5.12 DePuy Synthes Inc Company Overview
5.12.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Evasc Medical Systems Corp Company Overview
5.13.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Integra LifeSciences Holdings Corp Company Overview
5.15 Mayo Clinic Company Overview
5.15.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
5.16 Medtronic Plc Company Overview
5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.17 MicroPort NeuroTech Shanghai Co Ltd Company Overview
5.17.1 MicroPort NeuroTech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 MicroVention Inc Company Overview
5.18.1 MicroVention Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Monarch Biosciences Inc Company Overview
5.19.1 Monarch Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 NEOS Surgery SL Company Overview
5.20.1 NEOS Surgery SL Pipeline Products & Ongoing Clinical Trials Overview
5.21 Neurosigma Inc Company Overview
5.21.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Qvanteq AG Company Overview
5.22.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
5.23 RWTH Aachen University Company Overview
5.23.1 RWTH Aachen University Pipeline Products & Ongoing Clinical Trials Overview
5.24 Shape Memory Therapeutics, Inc. Company Overview
5.24.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.26 Stryker Neurovascular Company Overview
5.26.1 Stryker Neurovascular Pipeline Products & Ongoing Clinical Trials Overview
5.27 Terumo Corp Company Overview
5.27.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.28 Transverse Medical Inc Company Overview
5.28.1 Transverse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of California Los Angeles Company Overview
5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Minnesota Company Overview
5.30.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Wisconsin Madison Company Overview
5.31.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
5.32 Weill Cornell Medical College Company Overview
5.32.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview

6 Neurovascular Embolization Devices- Recent Developments
6.1 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education
6.2 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical
6.3 May 15, 2020: Microport orthopedics group brings in new strategic investors
6.4 Apr 15, 2020: J&J lifts dividend but cuts 2020 guidance
6.5 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
6.6 Mar 02, 2020: Stryker announces new Investor Relations leader
6.7 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum
6.8 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.9 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance
6.10 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.11 Feb 18, 2020: Cerus Endovascular gets CE Mark for Contour Neurovascular System
6.12 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.13 Feb 11, 2020: Metactive Medical Announces Name Change to Artio Medical
6.14 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
6.15 Feb 05, 2020: Stryker expands Flower Mound regional headquarters
6.16 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook
6.17 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard
6.18 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030
6.19 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results
6.20 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees
6.21 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
6.22 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point
6.23 Jan 09, 2020: MicroVention announces FDA premarket approval of a new flow diverter for the treatment of brain aneurysms
6.24 Jan 08, 2020: Terumo announces novel intrasaccular aneurysm treatment device receives approval in Japan
6.25 Dec 25, 2019: GST profiteering: Rs 230-crore penalty on Johnson & Johnson
6.26 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors
6.27 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Neurovascular Embolization Devices - Pipeline Products by Stage of Development
Table 2: Neurovascular Embolization Devices - Pipeline Products by Segment
Table 3: Neurovascular Embolization Devices - Pipeline Products by Territory
Table 4: Neurovascular Embolization Devices - Pipeline Products by Regulatory Path
Table 5: Neurovascular Embolization Devices - Pipeline Products by Estimated Approval Date
Table 6: Neurovascular Embolization Devices - Ongoing Clinical Trials
Table 7: Neurovascular Embolization Devices Companies - Pipeline Products by Stage of Development
Table 8: Neurovascular Embolization Devices - Pipeline Products by Stage of Development
Table 9: Ancure LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Drug-Eluting Embolization Coil - Product Status
Table 11: Drug-Eluting Embolization Coil - Product Description
Table 12: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Janjua Aneurysm Net - Product Status
Table 14: Janjua Aneurysm Net - Product Description
Table 15: Artio Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Ballstent Microcatheter - Product Status
Table 17: Ballstent Microcatheter - Product Description
Table 18: Endura Embolization Coils - Product Status
Table 19: Endura Embolization Coils - Product Description
Table 20: Endura Embolization Device - Product Status
Table 21: Endura Embolization Device - Product Description
Table 22: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Endovascular Embolization Device - Product Status
Table 24: Endovascular Embolization Device - Product Description
Table 25: Balt USA LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 26: SQUID Liquid Embolic Device - Product Status
Table 27: SQUID Liquid Embolic Device - Product Description
Table 28: Balt USA LLC - Ongoing Clinical Trials Overview
Table 29: SQUID Liquid Embolic Device - The Squid Trial for the Embolization of the Middle Meningeal Artery (STEM)
Table 30: BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 31: GelCoil - Product Status
Table 32: GelCoil - Product Description
Table 33: LiquiGel - Product Status
Table 34: LiquiGel - Product Description
Table 35: Cerenovus Pipeline Products & Ongoing Clinical Trials Overview
Table 36: BRAVO Flow Diverter - Product Status
Table 37: BRAVO Flow Diverter - Product Description
Table 38: EmboTrap Revascularization Device - Product Status
Table 39: EmboTrap Revascularization Device - Product Description
Table 40: Self-Expanding Stent - Product Status
Table 41: Self-Expanding Stent - Product Description
Table 42: Cerenovus - Ongoing Clinical Trials Overview
Table 43: EmboTrap Revascularization Device - A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke: SELECT 2
Table 44: Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Contour Neurovascular System - Product Status
Table 46: Contour Neurovascular System - Product Description
Table 47: Neqstent Coil Assisted Flow Diverter Device - Product Status
Table 48: Neqstent Coil Assisted Flow Diverter Device - Product Description
Table 49: Cerus Endovascular Ltd - Ongoing Clinical Trials Overview
Table 50: Contour Neurovascular System - Contour Neurovascular System - European Pre-market Unruptured Aneurysm Study (CERUS)

List of Figures
Figure 1: Neurovascular Embolization Devices - Pipeline Products by Stage of Development
Figure 2: Neurovascular Embolization Devices - Pipeline Products by Segment
Figure 3: Neurovascular Embolization Devices - Pipeline Products by Territory
Figure 4: Neurovascular Embolization Devices - Pipeline Products by Regulatory Path
Figure 5: Neurovascular Embolization Devices - Pipeline Products by Estimated Approval Date
Figure 6: Neurovascular Embolization Devices - Ongoing Clinical Trials